Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cell-based assay is a precise method of testing cell response using live cells in different experiments. Cell based assays utilize defined cells to gather information on a biopharmaceutical candidate. Cell based assays are commently used during drug discovery stages to identify parameters such as potential drug cytotoxicity, mechanism of action, and biological activity.
The global Cell-based Assay market was valued at US$ 16250 million in 2023 and is anticipated to reach US$ 26470 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
North America region dominated the global cell-based assay market in 2022
This report aims to provide a comprehensive presentation of the global market for Cell-based Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-based Assay.
Report Scope
The Cell-based Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-based Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-based Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
Consumption by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-based Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-based Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumable
1.2.3 Instrument
1.2.4 Service and Software
1.3 Market by Application
1.3.1 Global Cell-based Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-based Assay Market Perspective (2019-2030)
2.2 Cell-based Assay Growth Trends by Region
2.2.1 Global Cell-based Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-based Assay Historic Market Size by Region (2019-2024)
2.2.3 Cell-based Assay Forecasted Market Size by Region (2025-2030)
2.3 Cell-based Assay Market Dynamics
2.3.1 Cell-based Assay Industry Trends
2.3.2 Cell-based Assay Market Drivers
2.3.3 Cell-based Assay Market Challenges
2.3.4 Cell-based Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-based Assay Players by Revenue
3.1.1 Global Top Cell-based Assay Players by Revenue (2019-2024)
3.1.2 Global Cell-based Assay Revenue Market Share by Players (2019-2024)
3.2 Global Cell-based Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-based Assay Revenue
3.4 Global Cell-based Assay Market Concentration Ratio
3.4.1 Global Cell-based Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-based Assay Revenue in 2023
3.5 Cell-based Assay Key Players Head office and Area Served
3.6 Key Players Cell-based Assay Product Solution and Service
3.7 Date of Enter into Cell-based Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-based Assay Breakdown Data by Type
4.1 Global Cell-based Assay Historic Market Size by Type (2019-2024)
4.2 Global Cell-based Assay Forecasted Market Size by Type (2025-2030)
5 Cell-based Assay Breakdown Data by Application
5.1 Global Cell-based Assay Historic Market Size by Application (2019-2024)
5.2 Global Cell-based Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-based Assay Market Size (2019-2030)
6.2 North America Cell-based Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-based Assay Market Size by Country (2019-2024)
6.4 North America Cell-based Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-based Assay Market Size (2019-2030)
7.2 Europe Cell-based Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-based Assay Market Size by Country (2019-2024)
7.4 Europe Cell-based Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-based Assay Market Size (2019-2030)
8.2 Asia-Pacific Cell-based Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-based Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-based Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-based Assay Market Size (2019-2030)
9.2 Latin America Cell-based Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-based Assay Market Size by Country (2019-2024)
9.4 Latin America Cell-based Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-based Assay Market Size (2019-2030)
10.2 Middle East & Africa Cell-based Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-based Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-based Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkin Elmer
11.1.1 Perkin Elmer Company Detail
11.1.2 Perkin Elmer Business Overview
11.1.3 Perkin Elmer Cell-based Assay Introduction
11.1.4 Perkin Elmer Revenue in Cell-based Assay Business (2019-2024)
11.1.5 Perkin Elmer Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cell-based Assay Introduction
11.2.4 Danaher Corporation Revenue in Cell-based Assay Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Detail
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cell-based Assay Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cell-based Assay Business (2019-2024)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Cell-based Assay Introduction
11.4.4 Merck KGaA Revenue in Cell-based Assay Business (2019-2024)
11.4.5 Merck KGaA Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Cell-based Assay Introduction
11.5.4 Agilent Technologies Revenue in Cell-based Assay Business (2019-2024)
11.5.5 Agilent Technologies Recent Development
11.6 Attana
11.6.1 Attana Company Detail
11.6.2 Attana Business Overview
11.6.3 Attana Cell-based Assay Introduction
11.6.4 Attana Revenue in Cell-based Assay Business (2019-2024)
11.6.5 Attana Recent Development
11.7 BioVision
11.7.1 BioVision Company Detail
11.7.2 BioVision Business Overview
11.7.3 BioVision Cell-based Assay Introduction
11.7.4 BioVision Revenue in Cell-based Assay Business (2019-2024)
11.7.5 BioVision Recent Development
11.8 BMG LABTECH
11.8.1 BMG LABTECH Company Detail
11.8.2 BMG LABTECH Business Overview
11.8.3 BMG LABTECH Cell-based Assay Introduction
11.8.4 BMG LABTECH Revenue in Cell-based Assay Business (2019-2024)
11.8.5 BMG LABTECH Recent Development
11.9 Cayman Chemical
11.9.1 Cayman Chemical Company Detail
11.9.2 Cayman Chemical Business Overview
11.9.3 Cayman Chemical Cell-based Assay Introduction
11.9.4 Cayman Chemical Revenue in Cell-based Assay Business (2019-2024)
11.9.5 Cayman Chemical Recent Development
11.10 Corning
11.10.1 Corning Company Detail
11.10.2 Corning Business Overview
11.10.3 Corning Cell-based Assay Introduction
11.10.4 Corning Revenue in Cell-based Assay Business (2019-2024)
11.10.5 Corning Recent Development
11.11 Eurofins DiscoverX
11.11.1 Eurofins DiscoverX Company Detail
11.11.2 Eurofins DiscoverX Business Overview
11.11.3 Eurofins DiscoverX Cell-based Assay Introduction
11.11.4 Eurofins DiscoverX Revenue in Cell-based Assay Business (2019-2024)
11.11.5 Eurofins DiscoverX Recent Development
11.12 ProQinase
11.12.1 ProQinase Company Detail
11.12.2 ProQinase Business Overview
11.12.3 ProQinase Cell-based Assay Introduction
11.12.4 ProQinase Revenue in Cell-based Assay Business (2019-2024)
11.12.5 ProQinase Recent Development
11.13 XENOMETRIX
11.13.1 XENOMETRIX Company Detail
11.13.2 XENOMETRIX Business Overview
11.13.3 XENOMETRIX Cell-based Assay Introduction
11.13.4 XENOMETRIX Revenue in Cell-based Assay Business (2019-2024)
11.13.5 XENOMETRIX Recent Development
11.14 Promega Corporation
11.14.1 Promega Corporation Company Detail
11.14.2 Promega Corporation Business Overview
11.14.3 Promega Corporation Cell-based Assay Introduction
11.14.4 Promega Corporation Revenue in Cell-based Assay Business (2019-2024)
11.14.5 Promega Corporation Recent Development
11.15 Becton, Dickinson and Company
11.15.1 Becton, Dickinson and Company Company Detail
11.15.2 Becton, Dickinson and Company Business Overview
11.15.3 Becton, Dickinson and Company Cell-based Assay Introduction
11.15.4 Becton, Dickinson and Company Revenue in Cell-based Assay Business (2019-2024)
11.15.5 Becton, Dickinson and Company Recent Development
11.16 Charles River Laboratories, Inc.
11.16.1 Charles River Laboratories, Inc. Company Detail
11.16.2 Charles River Laboratories, Inc. Business Overview
11.16.3 Charles River Laboratories, Inc. Cell-based Assay Introduction
11.16.4 Charles River Laboratories, Inc. Revenue in Cell-based Assay Business (2019-2024)
11.16.5 Charles River Laboratories, Inc. Recent Development
11.17 Lonza Group Ltd.
11.17.1 Lonza Group Ltd. Company Detail
11.17.2 Lonza Group Ltd. Business Overview
11.17.3 Lonza Group Ltd. Cell-based Assay Introduction
11.17.4 Lonza Group Ltd. Revenue in Cell-based Assay Business (2019-2024)
11.17.5 Lonza Group Ltd. Recent Development
11.18 Cell Signaling Technology, Inc.
11.18.1 Cell Signaling Technology, Inc. Company Detail
11.18.2 Cell Signaling Technology, Inc. Business Overview
11.18.3 Cell Signaling Technology, Inc. Cell-based Assay Introduction
11.18.4 Cell Signaling Technology, Inc. Revenue in Cell-based Assay Business (2019-2024)
11.18.5 Cell Signaling Technology, Inc. Recent Development
11.19 Cell Biolabs, Inc.
11.19.1 Cell Biolabs, Inc. Company Detail
11.19.2 Cell Biolabs, Inc. Business Overview
11.19.3 Cell Biolabs, Inc. Cell-based Assay Introduction
11.19.4 Cell Biolabs, Inc. Revenue in Cell-based Assay Business (2019-2024)
11.19.5 Cell Biolabs, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research